Small molecule chemical probes of microRNA function

Current Opinion in Chemical Biology

Volumn 24, Issue , 2015, Pages 97-103

  Velagapudi, Sai Pradeep ^a   Vummidi, Balayeshwanth R ^a   Disney, Matthew D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; DROSHA PROTEIN; MESSENGER RNA; MICRORNA; NUCLEASE; UNCLASSIFIED DRUG; MOLECULAR LIBRARY; MOLECULAR PROBE;

APOPTOSIS; BIOGENESIS; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; RNA PROBE; RNA SEQUENCE; VIRUS LOAD; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; GENETIC PROCEDURES; GENETICS; METABOLISM; MOLECULAR GENETICS; MOLECULAR LIBRARY; MOLECULAR PROBE; NUCLEOTIDE SEQUENCE; PHARMACOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; DRUG DISCOVERY; HUMANS; MICRORNAS; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; SMALL MOLECULE LIBRARIES; TRANSCRIPTIONAL ACTIVATION;

EID: 84916236919     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2014.10.024     Document Type: Review

References (48)

1. Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 2005, 361:13-37.
2. Bayne E.H., Allshire R.C. RNA-directed transcriptional gene silencing in mammals. Trends Genet 2005, 21:370-373.
3. Nudler E., Mironov A.S. The riboswitch control of bacterial metabolism. Trends Biochem Sci 2004, 29:11-17.
4. Parsons J., Castaldi M.P., Dutta S., Dibrov S.M., Wyles D.L., Hermann T. Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nat Chem Biol 2009, 5:823-825.
5. Davidson A., Leeper T.C., Athanassiou Z., Patora-Komisarska K., Karn J., Robinson J.A., Varani G. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein. Proc Natl Acad Sci U S A 2009, 106:11931-11936.
6. Yonath A., Bashan A. Ribosomal crystallography: initiation, peptide bond formation, and amino acid polymerization are hampered by antibiotics. Annu Rev Microbiol 2004, 58:233-251.
7. Dervan P. Design of sequence-specific DNA-binding molecules. Science 1986, 232:464-471.
8. Nielsen P.E. Design of sequence-specific DNA-binding ligands. Chem Eur J 1997, 3:505-508.
9. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 2006, 5:993-996.
10. White S., Szewczyk J.W., Turner J.M., Baird E.E., Dervan P.B. Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature 1998, 391:468-471.
11. Guan L., Disney M.D. Recent advances in developing small molecules targeting RNA. ACS Chem Biol 2012, 7:73-86.
12. Thomas J.R., Hergenrother P.J. Targeting RNA with small molecules. Chem Rev 2008, 108:1171-1224.
13. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
14. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158.
15. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
16. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005, 2:269-276.
17. Cai X., Hagedorn C.H., Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004, 10:1957-1966.
18. Kirigin F.F., Lindstedt K., Sellars M., Ciofani M., Low S.L., Jones L., Bell F., Pauli F., Bonneau R., Myers R.M., et al. Dynamic microRNA gene transcription and processing during T cell development. J Immunol 2012, 188:3257-3267.
19. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004, 18:3016-3027.
20. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
21. Okamura K., Liu N., Lai E.C. Distinct mechanisms for microRNA strand selection by Drosophila Argonautes. Mol Cell 2009, 36:431-444.
22. Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Zhou Y.H., Chen W., Khaitovich P. Sequence features associated with microRNA strand selection in humans and flies. BMC Genomics 2009, 10:413.
23. Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011, 12:99-110.
24. Ameres S.L., Zamore P.D. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 2013, 14:475-488.
25. Mullokandov G., Baccarini A., Ruzo A., Jayaprakash A.D., Tung N., Israelow B., Evans M.J., Sachidanandam R., Brown B.D. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 2012, 9:840-846.
26. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011, 91:827-887.
27. Garzon R., Calin G.A., Croce C.M. MicroRNAs in Cancer. Annu Rev Med 2009, 60:167-179.
28. Swarbrick A., Woods S.L., Shaw A., Balakrishnan A., Phua Y., Nguyen A., Chanthery Y., Lim L., Ashton L.J., Judson R.L., et al. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. Nat Med 2010, 16:1134-1140.
29. Li Z., Rana T.M. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 2014, 13:622-638.
30. He L., He X., Lowe S.W., Hannon G.J. microRNAs join the p53 network - another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007, 7:819-822.
31. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
32. Chang T.C., Yu D., Lee Y.S., Wentzel E.A., Arking D.E., West K.M., Dang C.V., Thomas-Tikhonenko A., Mendell J.T. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008, 40:43-50.
33. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
34. Rybak A., Fuchs H., Smirnova L., Brandt C., Pohl E.E., Nitsch R., Wulczyn F.G. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 2008, 10:987-993.
35. Gumireddy K., Young D.D., Xiong X., Hogenesch J.B., Huang Q., Deiters A. Small-molecule inhibitors of microRNA miR-21 function. Angew Chem Int Ed Engl 2008, 47:7482-7484.
36. Kumarswamy R., Volkmann I., Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol 2011, 8:706-713.
37. Gramantieri L., Ferracin M., Fornari F., Veronese A., Sabbioni S., Liu C.G., Calin G.A., Giovannini C., Ferrazzi E., Grazi G.L., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007, 67:6092-6099.
38. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
39. Young D.D., Connelly C.M., Grohmann C., Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 2010, 132:7976-7981.
40. Bose D., Jayaraj G., Suryawanshi H., Agarwala P., Pore S.K., Banerjee R., Maiti S. The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew Chem Int Ed Engl 2012, 51:1019-1023.
41. Vo D.D., Staedel C., Zehnacker L., Benhida R., Darfeuille F., Duca M. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules. ACS Chem Biol 2014, 9:711-721.
42. Velagapudi S.P., Gallo S.M., Disney M.D. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat Chem Biol 2014, 10:291-297.
43. Disney M.D., Labuda L.P., Paul D.J., Poplawski S.G., Pushechnikov A., Tran T., Velagapudi S.P., Wu M., Childs-Disney J.L. Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. J Am Chem Soc 2008, 130:11185-11194.
44. Velagapudi S.P., Seedhouse S.J., Disney M.D. Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules. Angew Chem Int Ed Engl 2010, 49:3816-3818.
45. Lin H., Dai T., Xiong H., Zhao X., Chen X., Yu C., Li J., Wang X., Song L. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS ONE 2010, 5:e15797.
46. Guttilla I.K., White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204-23216.
47. Velagapudi S.P., Disney M.D. Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor. Chem Commun 2014, 50:3027-3029.
48. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.